angiotensin ii has been researched along with boldine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blázquez, MA; Cerdá-Nicolás, M; Cortijo, J; Estellés, R; Issekutz, AC; Ivorra, MD; Losada, M; Mateo, T; Milian, L; Morcillo, EJ; Nabah, YN; Sanz, MJ | 1 |
| Huang, Y; Lau, CW; Lau, YS; Liu, J; Murugan, D; Mustafa, MR; Tian, XY; Zhang, Y | 1 |
2 other study(ies) available for angiotensin ii and boldine
| Article | Year |
|---|---|
Effect of boldine, secoboldine, and boldine methine on angiotensin II-induced neutrophil recruitment in vivo.
Topics: Angiotensin II; Animals; Aporphines; Chemokine CXCL2; Chemokines; Chemokines, CXC; Endothelial Cells; Humans; Infusions, Parenteral; Intercellular Signaling Peptides and Proteins; Interleukin-8; Keratinocytes; Male; Molecular Structure; Monokines; Neutrophils; P-Selectin; Phenanthrenes; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species | 2005 |
Boldine improves endothelial function in diabetic db/db mice through inhibition of angiotensin II-mediated BMP4-oxidative stress cascade.
Topics: Angiotensin II; Animals; Antioxidants; Aorta, Thoracic; Aporphines; Bone Morphogenetic Protein 4; Cells, Cultured; Diabetes Mellitus, Type 2; Endothelial Cells; Endothelium, Vascular; In Vitro Techniques; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Nitric Oxide Synthase Type III; Oxidative Stress; Receptor, Angiotensin, Type 1; Vasodilation | 2013 |